JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

Search

DexCom Inc

Suletud

SektorTervishoid

89.05 2.62

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

88.59

Max

89.06

Põhinäitajad

By Trading Economics

Sissetulek

-46M

105M

Müük

-78M

1B

P/E

Sektori keskmine

63.18

38.156

Aktsiakasum

0.32

Kasumimarginaal

10.174

Töötajad

10,200

EBITDA

-109M

134M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+11.77% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

30. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-1.6B

33B

Eelmine avamishind

86.43

Eelmine sulgemishind

89.05

Uudiste sentiment

By Acuity

50%

50%

145 / 375 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

DexCom Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

1. juuli 2025, 18:41 UTC

Omandamised, ülevõtmised, äriostud

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

25. okt 2024, 09:10 UTC

Tulu

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

DexCom Inc Prognoos

Hinnasiht

By TipRanks

11.77% tõus

12 kuu keskmine prognoos

Keskmine 99.46 USD  11.77%

Kõrge 110 USD

Madal 86.67 USD

Põhineb 20 Wall Streeti analüütiku instrumendi DexCom Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

20 ratings

18

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

71.66 / N/AToetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Neutral Evidence

Sentiment

By Acuity

145 / 375 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.